Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentosan polysulfate for knee osteoarthritis with bone marrow lesions
ACTRN12617001311347Phase 2Completed
- Sponsor
- Paradigm Biopharmaceuticals
- Start
- Oct 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Pentosan polysulfate sodium with Saline placebo (2 arms). Primary endpoint: Change in KOOS Pain score from baseline to Day 53. Started Oct 2017; status: completed.
02
Drugs
pentosan polysulfate sodium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12617001311347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001311347.